Three Different Cannabinoid-Based Medicines Approved by the FDA

ShovelHead

Bikes don't leak oil, they mark their territory!
The U.S. Food and Drug Administration (FDA) is aware that cannabis and cannabis-derived products are being used for a number of medical conditions, such as AIDS wasting syndrome, epilepsy, neuropathic pain, treatment of spasticity associated with multiple sclerosis, and cancer and chemotherapy-induced nausea.

Despite this fact, the FDA has not yet approved a marketing application for a drug product containing or derived from the whole cannabis plant. It has, however, approved three cannabinoid-based medicines derived from isolated synthetics:

Click Here to Read More
 

C No Ego

Well-Known Member
Now science has found 568 components in cannaibs species.... # 568 #
take all other plants in the world and examine their components.... none even come close to 568 constituent parts

88 of those constituent cannabis parts are unquestionably bio active and have direct medicinal value for humans...

the three synthetic formulas are not approaching much activity on active organisms such as the human species which requires complexities of expression ( living plant expression with every component working bio living like as the life of the species presents itself upon the void)... absolute expression from nothing... try and duplicate that big pharma ( What?) ... it requires intelligence much greater................
 
Top Bottom